Acrux Ltd ARUXF:OTCPK

*Data is delayed | Exchange | USD
Last | 01/08/24 EDT
0.0306UNCH (UNCH)
52 week range
0.03 - 0.04
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0306
  • 52 Week High0.04
  • 52 Week High Date01/08/24
  • 52 Week Low0.03
  • 52 Week Low Date01/08/24

Key Stats

  • Market Cap11.15M
  • Shares Out289.63M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0306
  • 52 Week High0.04
  • 52 Week High Date01/08/24
  • 52 Week Low0.03
  • 52 Week Low Date01/08/24
  • Market Cap11.15M
  • Shares Out289.63M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.00
  • P/E (TTM)-18.97
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/14/2015
  • Div Amount0.06
  • Split Date-
  • Split Factor-

Latest On Acrux Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is engaged in developing and commercializing a pipeline of topically applied pharmaceutical products. Its products include Lidocaine and Prilocaine Cream, USP 2.5%/2.5%, Lenzetto, Evamist and Testosterone Topical Solution, 30 mg / 1.5 ml. Lidocaine and Prilocaine Cream USP (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on normal intact...
Ross Dobinson
Independent Non-Executive Chairman of the Board
Michael Kotsanis
Chief Executive Officer, Managing Director, Executive Director
Joanna Johnson
Chief Financial Officer, Company Secretary
Address
103-113 Stanley St, West Melbourne
Melbourne, VIC
3003
Australia